Terms ending in 2043
Every in-force patent on AstraZeneca AB's record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,617,795 | SUBSTITUTED 6,7-Dihydro-5H-PYRROLO[3,4-d]PYRIMIDINES, 5,7-Dihydrofuro[3,4-d]PYRIMIDINES, AND PYRIDO[2,3-d]PYRIMIDINES AS KCC2 MODULATORS In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 12,240,832 | IRAK4 Inhibitors In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 12,613,173 | Apparatus and Method for Evaluating Physical Strength or Robustness of Solid Pharmaceutical Dosage Forms Based on an Impact Strike Test In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 12,502,398 | Combination Therapy for Treating Cancer In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 12,486,316 | Antibodies That Bind the Spike Protein of SARS-COV-2 In force · High confidence | AstraZeneca UK Limited | In force | High confidence | |
| US 12,291,524 | Amido Heteroaromatic Compounds In force · Medium confidence | AstraZeneca AB | In force | Medium confidence | |
| US 12,758,644 | Peptide Dendrons and Methods of Use Thereof In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 12,758,646 | Combination of Antibody-Drug Conjugate and CDK9 Inhibitor In force · High confidence | AstraZeneca UK Limited and Daiichi Sankyo Company, Limited | In force | High confidence | |
| US 12,667,541 | Dry Powder Formulation for Pulmonary Delivery and Methods of Use In force · High confidence | AstraZeneca AB | In force | High confidence | |
| US 12,678,444 | Substituted PYRAZINE-2-Carboxamides as HPK1 Inhibitors for the Treatment of Cancer In force · High confidence | AstraZeneca AB | In force | High confidence | |
| 9 more term ends in 2043 · Pro | |||||
10 of 19 patents shown. Soonest term end first, then patent number.
Pro members see all 19.
18 of these are in force and held by AstraZeneca AB.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.